More about

Biomarker

News
September 16, 2024
2 min read
Save

Putative retinal gliosis may serve as biomarker for preclinical Alzheimer’s disease

Putative retinal gliosis may serve as biomarker for preclinical Alzheimer’s disease

Patients with preclinical Alzheimer’s disease had significantly greater putative retinal gliosis compared with controls, according to study results published in Investigative Ophthalmology & Visual Science.

News
September 09, 2024
2 min read
Save

Plasma biomarkers help determine sports-related concussion neuropathology

Plasma biomarkers help determine sports-related concussion neuropathology

Plasma biomarkers shed light on concussion-related neuropathology in adolescents who played contact sports in Canada, supporting their use in pathophysiology, according to new research.

News
September 09, 2024
2 min read
Save

Despite progress, barriers to lung cancer biomarker testing persist

Despite progress, barriers to lung cancer biomarker testing persist

Acceptance and utilization of lung cancer biomarker testing has increased in the past 6 years, but key barriers persist, according to survey results.

News
September 09, 2024
2 min watch
Save

VIDEO: Ellipsoid zone an important biomarker in geographic atrophy

VIDEO: Ellipsoid zone an important biomarker in geographic atrophy

In this video, Barbara Blodi, MD, discusses the importance of the ellipsoid zone as a biomarker in patients with geographic atrophy.

News
August 22, 2024
2 min read
Save

Prognostic tool may identify those with BE at higher risk for developing esophageal cancer

Prognostic tool may identify those with BE at higher risk for developing esophageal cancer

The biomarker-based Esopredict determined that patients with Barrett’s esophagus who were stratified as higher risk were 6.4-times more likely to progress to high-grade dysplasia or esophageal adenocarcinoma within 5 years, research showed.

News
August 02, 2024
1 min read
Save

Lecanemab slows progression of novel Alzheimer’s-related biomarker over 18 months

Lecanemab slows progression of novel Alzheimer’s-related biomarker over 18 months

PHILADELPHIA — Treatment with lecanemab slowed the progression of a potential novel Alzheimer’s disease-related biomarker by 44% over 18 months compared with placebo, with the biomarker itself most correlating with tauopathy, data show.

News
August 01, 2024
2 min read
Save

Suvorexant acutely effective in reducing Alzheimer’s-related biomarkers

Suvorexant acutely effective in reducing Alzheimer’s-related biomarkers

PHILADELPHIA — In cognitively healthy but sleep-poor adults in midlife, treatment with 20 mg suvorexin led to acute decreases in Alzheimer’s-related biomarkers compared with 10 mg of the drug and placebo, according to a presenter.

News
July 30, 2024
2 min read
Save

Sociodemographic factors linked to likelihood of biomarker testing in colorectal cancer

Sociodemographic factors linked to likelihood of biomarker testing in colorectal cancer

Sociodemographic factors may contribute to disparities in testing for two key biomarkers among patients with metastatic colorectal cancer, according to study results.

News
July 25, 2024
2 min read
Save

Blood biomarker identifying benign lung nodules performs well across subgroups

Blood biomarker identifying benign lung nodules performs well across subgroups

A blood biomarker used to identify benign vs. malignant pulmonary nodules displayed “excellent” performance regardless of sex, smoking status, screen detection and nodule size, according to a research letter published in CHEST.

News
July 12, 2024
6 min read
Save

‘Follow the science and follow your gut’ to make a change in medicine

‘Follow the science and follow your gut’ to make a change in medicine

Emma Guttman-Yassky, MD, PhD, lives her life in dichotomy. She’s a dermatologist and an immunologist; a researcher and a department chair; and her medical and research experience transcends the globe, from North America to Europe.

View more